Orthopedics in Alabama

Simparo Surgical develops the Anchor Line Fixation System, a specialized surgical instrument platform for thumb carpometacarpal (CMC) suspensionplasty reconstruction. The system addresses basal joint arthritis through a minimally invasive, single-incision approach that avoids bone tunnels and tendon harvesting. The core innovation is the patented Falcon Suture Clutch—a proprietary tensioning and cinching device that allows surgeons to apply controlled tension to the suspension sling, lock it intraoperatively, and achieve stable, bone-to-bone fixation using titanium suture anchors. The Anchor Line Fixation System combines two driver handles, one K-wire, and one drill bit for straightforward instrumentation. It performs trapeziectomy with anchor placement into the base of the index metacarpal and intra-articular base of the thumb metacarpal, enabling anatomic reconstruction while reducing operative time by up to 67% compared to traditional ligament reconstruction and tendon interposition (LRTI). The procedure supports early return to passive motion within 2 weeks. Simparo's approach is grounded in the long-term clinical success of Suture Suspension Arthroplasty (SSA) developed by Jeanne DelSignore, MD, whose 12–14 year follow-up data received the 2021 Sumner Koch Award from the American Society for Surgery of the Hand. The system is designed for hand surgeons and orthopedic specialists treating thumb CMC arthritis with emphasis on reproducibility, stability, and reduced technical complexity across varying soft tissue quality.

MACB, LLC manufactures the MACB® Introducer, a surgeon-placed adductor canal block device designed for intraoperative regional analgesia in total knee arthroplasty (TKA) procedures. The device enables surgeons to deliver non-opioid pain management directly during surgery, providing 4–5 days of pain relief and facilitating same-day discharge for outpatient TKA in ambulatory surgery centers. The MACB® Introducer offers both catheter-based therapy and non-catheter options using liposomal bupivacaine, eliminating the need for additional anesthesia procedures and reducing opioid-related complications and hospital stays. Developed by Dr. Daniel Matthews, MD, FAAOS, an orthopedic surgeon with 30+ years of experience, the device has been extensively validated in clinical practice with over 2,100 placements and peer-reviewed publications demonstrating superior nerve coverage compared to ultrasound-guided blocks alone. The company distributes catheter-based therapy products exclusively through Avanos Medical Technologies in the United States. MACB targets orthopedic surgeons and surgical centers seeking to implement opioid-free pain management protocols for knee arthroplasty.